Showing results (41-50 of 56) with videos related to
Sort By:
Pageof 6
Environmental Pollution (Barking, Essex : 1987)|November 11, 2017
Characterizing isotopic compositions of TC-C, NO3<sup>-</sup>-N, and NH<sub>4</sub><sup>+</sup>-N in PM<sub>2.5</sub> in South Korea: Impact of China's winter heatingYu-Mi Park, Kwang-Su Park, Hyuk Kim, et al.Toxics|August 6, 2021
Comparative Cytotoxicity Study of PM2.5 and TSP Collected from Urban AreasIlseob Shim, Woong Kim, Haewon Kim, et al.Nature Chemical Biology|December 11, 2019
Discovery of a first-in-class EZH2 selective degraderAnqi Ma, Elias Stratikopoulos, Kwang-Su Park, et al.Journal of Medicinal Chemistry|February 16, 2026
Discovery of a Potent, Selective, and In Vivo Efficacious Covalent Inhibitor for Lysine Methyltransferase SETD8He Chen, Rudra Prasad Dutta, Zhizhong Li, et al.Journal of the American Chemical Society|September 14, 2021
Harnessing the E3 Ligase KEAP1 for Targeted Protein DegradationJieli Wei, Fanye Meng, Kwang-Su Park, et al.Journal of Medicinal Chemistry|May 6, 2020
Discovery of a First-in-Class Protein Arginine Methyltransferase 6 (PRMT6) Covalent InhibitorYudao Shen, Fengling Li, Magdalena M Szewczyk, et al.International Journal of Molecular Sciences|June 2, 2021
Structure-Based Design, Docking and Binding Free Energy Calculations of A366 Derivatives as Spindlin1 InhibitorsChiara Luise, Dina Robaa, Pierre Regenass, et al.Research Square|December 4, 2023
Novel brain-penetrant inhibitor of G9a methylase blocks Alzheimer's disease proteopathology for precision medicationXian Chen, Ling Xie, Ryan Sheehy, et al.Medrxiv : the Preprint Server for Health Sciences|November 14, 2023
Novel brain-penetrant inhibitor of G9a methylase blocks Alzheimer's disease proteopathology for precision medicationLing Xie, Ryan N Sheehy, Yan Xiong, et al.Nature Cell Biology|February 25, 2022
EZH2 noncanonically binds cMyc and p300 through a cryptic transactivation domain to mediate gene activation and promote oncogenesisJun Wang, Xufen Yu, Weida Gong, et al.Pageof 6